Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
3 Growth Trends in $472 Billion Global Medical Device Market
COVID-19, mergers & acquisitions, and innovation spurred notable gains in the sale of medical devices in 2020 The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report […]
At-Home Testing Expanding Reach Beyond COVID-19 Pandemic
Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the […]
Point of Care Test Market is Ravaged, and Helped By Pandemic
Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own. In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse. That’s up double digits from […]
Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report
There’s much talk about cell and gene therapy but a new report from a leading market research firm says that there’s a growing market over nearly two billion dollars for companies that make the cell and gene therapies. In 2020, the total global cell and gene therapy BCMO market reached $1,842 million. Over the following […]
Global Biomarker Test Product Sales to Reach $63 Billion in 2027
Total global sales of biomarker test products are projected to reach nearly $63 billion in 2027 with the majority of sales coming from the United States, Western Europe, and Japan, according to new data by leading medical market research publisher Kalorama Information in the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, […]
Global IVD Procedures to Grow to 111.3 Billion Annually…Here’s Why
There are currently 76.1 billion in vitro diagnostics (IVD) procedures annually worldwide. Global IVD procedure volumes are forecast to grow by several billion more through 2025, as revealed in IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests, a recent report by Kalorama Information. IVD procedures range from glucose to procedures including […]
FDA Approves Novel Cell Therapy for Multiple Myeloma
Modern developments in cell and gene therapy products are transforming the treatment of cancers and genetic diseases, and in the process they have helped create a multi-billion dollar global industry that is poised to more than double over the next ten years, according to 2020 estimates by leading medical market research firm Kalorama Information as […]
COVID-19 Diagnostics Market Reaches 32.5BN in 2022. Antigens. Long COVID-19 Driving Spending. Qiagen, Cue Health Other News
Hundreds of Tests on The Market, U.S. Labs Mostly Use Ten
As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits. There have been hundreds of tests on the market receiving EUAs from the Food and Drug Administration, but a survey from the Association of Molecular Pathology demonstrated that only a few are used by laboratories. As part of its survey: https://www.amp.org/advocacy/sars-cov-2-survey/ labs were asked their top ten testing methods. Among them: Abbott m2000, Roche cobas were the top two vendors in most labs’ top tens.
Roche GenMark Deal – COVID-19 Makes Respiratory Segment and mPOC More Valuable
A recent deal in the news cements the viability of the respiratory segment and the use of small molecular systems to test for them. First introduced in 2013, PCR and other NAAT-based molecular systems have become a central part of testing for ailments such as flu, strep, RSV and COVID-19. They remain in competition with […]
IVD Procedures – 76.1 Billion Annually and Growing
There are currently 76.1 billion in vitro diagnostics procedures annually. Procedure volumes will grow to 111.3 billion in 2025.The chart below depicts the current global estimate and forecast of IVD procedures, including glucose and excluding COVID-19. Population, aging, insurance levels and new test development are factors in the growth of procedures. Global volumes of […]